Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer.

Cancers (Basel) · 2023 · PMC10296610 · PMID 37370781

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

Patients with CHE who received adjuvant therapy seemed to have improved 5-year DFS rates compared to those who did not receive adjuvant therapy (HR = 0.226, [95% CI: 0.050–1.013]), and patients with CHO who did not receive adjuvant therapy had higher risks of tumor recurrence, metastasis, or mortality (HR = 2.028, [95% CI: 1.002–4.102]); although both associations were only marginally significant.

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.